Vladimir I. Slepnev
Oprichter bij Curative, Inc.
Profiel
Vladimir I.
Slepnev is the founder who has founded two companies.
In 2004, he founded PrimeraDx, Inc. where he held the title of Chief Technical Officer from 2009 to 2010.
In 2020, he founded Curative, Inc. where he currently holds the title of Chief Scientific Officer.
Dr. Slepnev's former jobs include Director-Molecular Biology at Sention, Inc. and Faculty Member at Yale University.
Dr. Slepnev's education history includes a graduate degree from Moscow State University.
Actieve functies van Vladimir I. Slepnev
| Bedrijven | Functie | Begin |
|---|---|---|
Curative, Inc.
 Curative, Inc. Medical DistributorsDistribution Services Curative, Inc. engages in the provision of .healthcare services. It provides oral fluid test services. The company was founded by Fred Turner, Isaac Turner, and Vladimir Slepnev in January 2020 and is headquartered in the United States. | Oprichter | 01-01-2020 |
Eerdere bekende functies van Vladimir I. Slepnev
| Bedrijven | Functie | Einde |
|---|---|---|
Sention, Inc.
 Sention, Inc. Pharmaceuticals: MajorHealth Technology Sention, Inc. manufactures pharmaceutical products. The company focuses on the discovery and development of drugs to treat memory impairment and other central nervous disorders. The company was founded in 1999 and is headquartered in Providence, RI | Corporate Officer/Principal | - |
| Yale University | Corporate Officer/Principal | - |
PrimeraDx, Inc.
 PrimeraDx, Inc. Medical SpecialtiesHealth Technology PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA. | Oprichter | - |
Opleiding van Vladimir I. Slepnev
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
PrimeraDx, Inc.
PrimeraDx, Inc. Medical SpecialtiesHealth Technology PrimeraDx, Inc. develops and commercializes molecular diagnostics systems. It offers ICEPlex System, an open platform that allows clinical researchers to design their assays for the development of multiplexed, multimodal, and quantitative in vitro diagnostic to simultaneously interrogate dozens of biomarkers in the same reaction. The company's ICEPlex System also enables to design complex multi-modal assays that test for disparate target types, such as SNPs, expression biomarkers, miRNAs, and fusion genes, as well as addresses research challenges in oncology, infectious diseases, translational medicine research, and pharma quality control. It also focuses on developing oncology products that are intended to support cancer research, diagnostics, and therapeutics; and companion diagnostics solutions that help pharmaceutical companies to design, develop, and validate custom CDx tests. The company was founded by Vladimir I. Slepnev in 2004 and is headquartered in Mansfield, MA. | Health Technology |
| Moscow State University | Consumer Services |
Sention, Inc.
Sention, Inc. Pharmaceuticals: MajorHealth Technology Sention, Inc. manufactures pharmaceutical products. The company focuses on the discovery and development of drugs to treat memory impairment and other central nervous disorders. The company was founded in 1999 and is headquartered in Providence, RI | Health Technology |
Curative, Inc.
Curative, Inc. Medical DistributorsDistribution Services Curative, Inc. engages in the provision of .healthcare services. It provides oral fluid test services. The company was founded by Fred Turner, Isaac Turner, and Vladimir Slepnev in January 2020 and is headquartered in the United States. | Distribution Services |